
Retatrutide
Triple-agonist (GIP / GLP-1 / glucagon)$40per research vial · USD
Retatrutide is a triple-agonist research peptide engaging GIP, GLP-1, and glucagon receptor pathways. A frequently referenced compound in preclinical metabolic and energy-balance investigations.
Available strengths
1
Certificate of Analysis
Search code: BGSR2607010572
Report date: 07/03/2026
Purity: 99.96%
View COAFor Research Use Only. Not for human or veterinary use. This product is intended strictly for in-vitro laboratory research and development and is sold to qualified researchers only.




